INOVIQ Breakthrough in Exosome Cancer Therapy

Inoviq Ltd (AU:IIQ) has released an update.

INOVIQ Limited has achieved a significant breakthrough in breast cancer treatment by successfully developing exosome-based therapeutics that target and kill cancer cells with enhanced precision. These engineered exosomes, derived from natural killer cells, demonstrated a promising ability to kill a substantial percentage of aggressive breast cancer cells, showcasing potential for future clinical applications. The company plans to advance this technology through further studies, aiming to refine and optimize its therapeutic efficacy.

For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.